Cholera Treatment: Oral Rehydration Solution and Intravenous (IV) Fluids

The small intestine lining, where ORS sugar draws salt and water in
The small intestine lining, where ORS sugar draws salt and water in

Cholera kills through dehydration — sometimes within hours — yet the treatment is deceptively simple: replacing the salt, sugar, and water your body is losing faster than it can hold on to them. Oral Rehydration Solution (ORS) is one of medicine's most impactful discoveries, saving an estimated 50 million lives since the 1970s by converting a disease with a 50% untreated mortality rate to less than 1% when managed correctly. This article explains exactly how ORS works, how to prepare it at home in an emergency, when intravenous (IV) fluids are needed, and how to monitor whether the treatment is working.

Table of Contents

  1. WHO ORS Composition
  2. How Glucose-Sodium Co-Transport Works
  3. Home Preparation in Emergencies
  4. Rate of ORS Administration
  5. Managing Vomiting During ORS
  6. Ringer's Lactate Intravenous for Severe Dehydration
  7. Rice-Based ORS and Cereal Solutions
  8. Zinc Supplementation for Children
  9. Monitoring Response to Rehydration
  10. Transitioning from Intravenous to Oral Rehydration
  11. Key Research Papers
  12. Connections
  13. Featured Videos

WHO ORS Composition

The current WHO standard is the low-osmolarity ORS formula, adopted in 2002 after decades of refinement. It delivers a total osmolarity of 245 mOsm/L — lower than the older 311 mOsm/L formula — which reduces stool output and the risk of vomiting without compromising effectiveness. Every liter of correctly prepared ORS contains:

The 2002 switch from high- to low-osmolarity ORS followed clinical trial evidence reviewed by WHO and UNICEF. A 2001 systematic review of 15 trials in 2,397 children admitted to hospital with diarrhea found that, compared with the older WHO solution, the lower-osmolarity solution meant fewer unplanned intravenous drips (odds ratio 0.61), less stool and less vomiting (odds ratio 0.71), with no significant difference in low blood sodium (hyponatremia) between the two groups (Hahn S et al., 2001, PMID: 11451782).

People with cholera lose salt much faster than people with ordinary diarrhea, so the lower-salt formula was also reviewed in cholera alone. A 2004 Cochrane review of 7 trials (718 people with cholera) found that a mild drop in blood sodium (serum sodium below 130 mmol/L) was more common with the lower-salt ORS (risk ratio 1.67; 4 trials, 465 people). A deeper drop (below 125 mmol/L) was not significantly more common, no trial reported low sodium that caused symptoms or any deaths, and the need for unplanned intravenous drips did not differ. The reviewers noted that the number of patients studied was small and that caution was warranted where patients are hard to monitor (Murphy C et al., 2004, PMID: 15495063).

Earlier work establishing the basic ORS framework showed that properly composed glucose-electrolyte solutions could match intravenous therapy in moderate dehydration.

Commercially packaged ORS sachets (such as WHO/UNICEF standard packets or generic ORS powders), like commercial pediatric electrolyte solutions, are pre-measured: a sachet is made to dissolve in exactly 1 liter of water. More or less water changes the strength of the solution, and the strength is what makes it work.

How Glucose-Sodium Co-Transport Works

To understand why ORS works — and why plain water or salt water alone does not — it helps to understand what cholera toxin actually does to the intestine.

Cholera toxin (CT) binds to the surface of intestinal cells (enterocytes) and permanently activates an enzyme called adenylate cyclase. This floods the cells with a chemical signal (cyclic AMP) that forces chloride channels (specifically CFTR — the same channel mutated in cystic fibrosis) to stay permanently open. Chloride pours out of the cells into the intestinal space, dragging sodium and water with it. The result is the massive, continuous watery diarrhea that makes cholera so lethal.

The critical insight, worked out by researchers in the 1950s and confirmed in cholera patients in the 1960s — among them a 1968 study of water and salt balance when a glucose-salt solution was run into the stomach of people with cholera (Pierce NF et al., 1968, PMID: 5675364) — is that SGLT1 (sodium-glucose cotransporter 1) is a completely separate molecule from CFTR, located on a different part of the cell surface, and is not affected by cholera toxin. SGLT1 is a transporter that requires both glucose and sodium to be present simultaneously in the gut; when they are, it carries two sodium particles (ions) together with each glucose molecule into the gut-lining cell, and water goes with them. A 1998 laboratory study of the human transporter (grown in frog egg cells) found that each trip of two sodium ions and one sugar molecule also moved about 210 water molecules through the transporter itself, and the authors estimated that this transporter could account for almost half of the water the small intestine takes back each day (Meinild A et al., 1998, PMID: 9490810). This is why the solution needs salt and sugar together.

This explains exactly why different approaches work or fail:

The discovery and application of this mechanism is considered one of the greatest public health achievements of the 20th century. Early clinical studies in Dhaka and Calcutta in the 1960s showed that carefully composed oral glucose-electrolyte solutions could maintain hydration in cholera patients who would otherwise have died (Sack DA et al., 2004, Lancet, PMID: 14738797).

Home Preparation in Emergencies

When ORS packets are unavailable — in remote areas, during disasters, or when supply chains break down — a home-prepared solution can be lifesaving. The WHO home recipe is:

Practical preparation points that go with the home recipe:

Coconut water, sports drinks and fruit juices are not equivalent to ORS. They have incorrect sodium concentrations and typically far too much sugar, which can worsen osmotic diarrhea. The treatment described for true cholera is WHO-formula ORS, or the home preparation above when packets are unavailable.

Rate of ORS Administration

How fast ORS is given depends on how dehydrated the patient is. WHO classifies dehydration into three categories, each with a different treatment plan:

Plan A — No signs of dehydration (mild loss, prevent worsening):

Plan B — Some signs of dehydration (moderate):

Plan C — Severe dehydration: intravenous fluids initially (see Section 6), then transition to ORS as soon as patient can drink.

Young children and infants are given ORS by spoon or small syringe (5–10mL at a time) rather than from a cup. A 10 kg toddler in Plan B needs approximately 750–1000mL over 3–4 hours — manageable with a syringe giving 5mL every 1–2 minutes. Pacing matters: giving it too fast causes vomiting, which wastes the fluid.

Managing Vomiting During ORS

Vomiting in cholera is common, especially in the first few hours of illness, and it can make patients and caregivers feel that ORS is "not working." This is almost never true. In cholera treatment, vomiting is handled by changing how ORS is given, not by stopping it.

The technique used for a vomiting patient is very small, very frequent sips:

If vomiting is severe enough that the patient cannot retain any ORS over a 2-hour period, the next step is a nasogastric (NG) tube. An NG tube is a thin flexible tube passed through the nose into the stomach; it allows ORS to be delivered continuously at the correct rate (75mL/kg over 4 hours for moderate dehydration) without requiring the patient to swallow. This is standard practice in cholera treatment centers and field hospitals — it is a routine, safe procedure even for children. Intravenous fluids are reserved for patients who:

In resource-limited settings where neither NG tube nor intravenous is available, persistent small-sip ORS by spoon every 1–2 minutes is still better than no treatment.

Ringer's Lactate Intravenous for Severe Dehydration

When a patient arrives with severe dehydration — unconscious or nearly so, pulse barely palpable, skin tenting severely, blood pressure unmeasurable — intravenous fluids are essential. Oral rehydration cannot work fast enough to reverse circulatory collapse.

Ringer's Lactate (Lactated Ringer's / Hartmann's Solution) is the WHO-preferred intravenous fluid for cholera. Its composition is:

The lactate is key: it is metabolized in the liver to bicarbonate, correcting the metabolic acidosis that accumulates in severe cholera. Normal saline (0.9% sodium chloride) is an acceptable second choice when Ringer's Lactate is unavailable, but it carries a risk of worsening hyperchloremic acidosis with large volumes because it contains only sodium and chloride (154 mEq/L each) and no buffer.

WHO dosing protocol for intravenous rehydration:

Ongoing stool losses are matched: approximately 1 mL of intravenous fluid (or ORS once tolerated) for every 1 mL of continuing stool output. In severe cholera, stool output can reach 500–1000 mL/hour, so this is not a trivial replacement burden.

Potassium supplementation: where serum potassium can be measured, it is checked — cholera causes severe potassium losses and hypokalemia can persist even after sodium and volume are restored. If serum K is below 3.0 mEq/L with electrocardiogram (EKG) changes (flattened T waves, U waves), additional potassium chloride is added to the intravenous bag under close monitoring.

Rice-Based ORS and Cereal Solutions

A significant body of research — particularly from South Asia and Bangladesh — has tested whether replacing glucose with cooked rice or rice flour in ORS produces better outcomes. The answer for cholera is yes: rice-based ORS appears superior to the older standard glucose ORS in cholera specifically, with a much smaller benefit in diarrhea not caused by cholera.

A 1992 meta-analysis of 13 trials (1,367 patients) found that, in the first 24 hours, rice-based ORS cut the rate of stool output by 36% in adults with cholera and by 32% in children with cholera, compared with the standard glucose WHO solution of that time — but by only 18% in infants and children with diarrhea not caused by cholera (Gore SM et al., 1992, PMID: 1531430). The mechanism is understood: rice starch is broken down slowly and progressively into individual glucose molecules in the intestine by amylase enzymes. This provides a sustained, steady supply of glucose molecules to activate SGLT1 without creating the large osmotic spike that pure glucose does. Less osmotic gradient in the gut means less water being pulled into the intestinal space — hence less stool volume.

How rice-based ORS is prepared:

WHO and UNICEF acknowledge rice-based ORS as clinically equivalent to glucose ORS, and superior in terms of stool volume reduction during cholera. In South Asian countries where rice is a staple, this is a practical and culturally familiar alternative. Other cereal starches (maize, wheat) have also been studied, though most trials have used rice.

A 2016 Cochrane review of 35 trials (4,284 people, cholera and non-cholera diarrhea) compared ORS made from starch "polymers" such as rice or wheat with glucose ORS. Against today's lower-salt glucose ORS (8 trials, 7 of them with rice), polymer ORS may shorten diarrhea by about 8 hours (5 trials) and may lower stool in the first 24 hours by about 24 mL per kg of body weight (one trial), with low-quality evidence and no clear difference in the need for unplanned intravenous drips; the authors judged this comparison underpowered. Against the older higher-salt glucose ORS (27 trials), polymer ORS may lower first-day stool by about 65 mL per kg and fewer people needed a drip — but in the subgroup of people with confirmed Vibrio cholerae, the need for an unplanned drip did not clearly differ (risk ratio 0.94) (Gregorio GV et al., 2016, PMID: 27959472).

Zinc Supplementation for Children

WHO and UNICEF recommend zinc supplementation for all children with acute diarrhea, including cholera. This is one of the most evidence-based and cost-effective additions to cholera management in pediatric patients.

Dosing:

What zinc actually does:

A 2008 meta-analysis of 22 placebo-controlled trials in children (16 trials of acute diarrhea with 15,231 children, 6 of persistent diarrhea with 2,968) found that zinc shortened acute diarrhea by 15.0% and persistent diarrhea by 15.5%, and lowered stool frequency by 18.8% and 12.5%. Vomiting after the dose was more common with zinc, and more common with zinc gluconate than with zinc sulfate or acetate. The authors wrote that how zinc stops diarrhea has not been fully worked out (Lukacik M et al., 2008, PMID: 18245424).

In cholera specifically, one double-blind, placebo-controlled trial at Dhaka Hospital, Bangladesh, gave 179 children aged 3–14 with culture-confirmed cholera either 30 mg of zinc a day or a placebo until recovery (all also received the antibiotic erythromycin). With zinc, diarrhea lasted 12% less time (64.1 v 72.8 hours), daily stool output was 11% lower (1.6 v 1.8 kg a day), and more children had recovered by day two (49% v 32%) and by day three (81% v 68%) (Roy SK et al., 2008, PMID: 18184631).

The WHO course runs the full 10–14 days, even after the child appears recovered — the mucosal healing benefits are described as extending beyond clinical recovery. Vomiting was more common with zinc in the 2008 meta-analysis above; mild nausea is a common complaint and is reported to lessen when zinc is given with a small amount of food or ORS.

Monitoring Response to Rehydration

Knowing whether treatment is working is as important as knowing how to give it. The most reliable single sign of successful rehydration is return of urine output. A patient who has not urinated in more than 4–6 hours is significantly dehydrated. As rehydration succeeds, urination returns — this is the kidney beginning to filter again.

Signs of improvement:

In clinical settings, additional monitoring includes:

A patient who does not improve after 3–4 hours of ORS at the correct rate — or who deteriorates — is a warning sign that cholera treatment centres treat as needing urgent reassessment. Possible explanations include: incorrect ORS concentration (a preparation error), inadequate intake (the patient not actually drinking the target volume), other complications (intestinal obstruction, severe acidosis, co-infection), or dehydration already severe enough to require intravenous fluids.

Transitioning from Intravenous to Oral Rehydration

Intravenous fluids are a bridge, not a destination. The goal of intravenous therapy in cholera is to restore circulatory volume and consciousness rapidly enough that the patient can then drink ORS themselves. Oral rehydration is preferred over intravenous for several reasons: it is physiologically more natural (engages the gut's normal absorptive mechanisms), far cheaper, does not require sterile equipment or trained insertion personnel, and avoids intravenous line complications such as infection, phlebitis, and fluid overload.

When to switch from intravenous to oral:

How the transition is usually made:

A common mistake is stopping fluid replacement too early because the patient "looks better." Cholera diarrhea can resume after an apparent improvement, and the patient can deteriorate again within hours. Replacement is continued for at least 24–48 hours after the last watery stool.

Food is reintroduced as soon as the patient can tolerate it rather than withheld during the recovery phase. Bland, easily digestible foods (rice, boiled potatoes, plain bread) alongside ORS support gut recovery and provide the energy needed to fight the ongoing infection. In children, resuming a normal age-appropriate diet as quickly as possible reduces the risk of malnutrition, which worsens cholera outcomes and is a significant contributor to post-cholera mortality in resource-limited settings.

Key Research Papers

  1. Sack DA, Sack RB, Nair GB, Siddique AK. Cholera. Lancet. 2004;363(9404):223-33. PubMed PMID: 14738797
  2. Pierce NF, Banwell JG, Rupak DM, Mitra RC, Caranasos GJ, Keimowitz RI, Mondal A, Manji PM. Effect of intragastric glucose-electrolyte infusion upon water and electrolyte balance in Asiatic cholera. Gastroenterology. 1968;55(3):333-43. PubMed PMID: 5675364
  3. Meinild A, Klaerke DA, Loo DD, Wright EM, Zeuthen T. The human Na+-glucose cotransporter is a molecular water pump. J Physiol. 1998;508(Pt 1):15-21. PubMed PMID: 9490810
  4. Hahn S, Kim Y, Garner P. Reduced osmolarity oral rehydration solution for treating dehydration due to diarrhoea in children: systematic review. BMJ. 2001;323(7304):81-5. PubMed PMID: 11451782
  5. Murphy C, Hahn S, Volmink J. Reduced osmolarity oral rehydration solution for treating cholera. Cochrane Database Syst Rev. 2004;(4):CD003754. PubMed PMID: 15495063
  6. Gore SM, Fontaine O, Pierce NF. Impact of rice based oral rehydration solution on stool output and duration of diarrhoea: meta-analysis of 13 clinical trials. BMJ. 1992;304(6822):287-91. PubMed PMID: 1531430
  7. Gregorio GV, Gonzales ML, Dans LF, Martinez EG. Polymer-based oral rehydration solution for treating acute watery diarrhoea. Cochrane Database Syst Rev. 2016;12(12):CD006519. PubMed PMID: 27959472
  8. Lukacik M, Thomas RL, Aranda JV. A meta-analysis of the effects of oral zinc in the treatment of acute and persistent diarrhea. Pediatrics. 2008;121(2):326-36. PubMed PMID: 18245424
  9. Roy SK, Hossain MJ, Khatun W, Chakraborty B, Chowdhury S, Begum A, Mah-e-Muneer S, Shafique S, Khanam M, Chowdhury R. Zinc supplementation in children with cholera in Bangladesh: randomised controlled trial. BMJ. 2008;336(7638):266-8. PubMed PMID: 18184631

Back to Table of Contents

Connections

Back to Table of Contents